A leap forward in assessing host-directed therapies for tuberculosis

Affiliations

¹ Divisions of Infectious Diseases and Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
² Divisions of Infectious Diseases and Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: kdooley1@jhmi.edu.

Comment

Elisa H Ignatius et al. Lancet Respir Med. 2021 Aug.

. 2021 Aug;9(8):809-810.

doi: 10.1016/S2213-2600(20)30528-2. Epub 2021 Mar 16.

¹ Divisions of Infectious Diseases and Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
² Divisions of Infectious Diseases and Clinical Pharmacology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: kdooley1@jhmi.edu.

No abstract available

Comment on

Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
Wallis RS, Ginindza S, Beattie T, Arjun N, Likoti M, Edward VA, Rassool M, Ahmed K, Fielding K, Ahidjo BA, Vangu MDT, Churchyard G. Wallis RS, et al. Lancet Respir Med. 2021 Aug;9(8):897-908. doi: 10.1016/S2213-2600(20)30448-3. Epub 2021 Mar 16. Lancet Respir Med. 2021. PMID: 33740465 Free PMC article. Clinical Trial.

1. WHO. Global tuberculosis report 2019. 2019. https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-en... (accessed Nov 2, 2020).
1. Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment, Thorax 2000; 55: 32–38. - PMC - PubMed
1. Ralph AP, Kenangalerm E, Waramori G, et al. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013; 8: e80302. - PMC - PubMed
1. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W,Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study, Chest 2000; 118: 656–64. - PubMed
1. Plit ML, Anderson R, Van Rensburg CE, et al. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J 1998; 12: 351–56. - PubMed